Durvalumab (anti-PD-L1)

Durvalumab (anti-PD-L1) is a selective, high affinity human IgG1 mAb that blocks programmed cell death ligand-1 (PD-L1) binding to PD-1 (IC50=0.1 nM) and CD80 (IC50=0.04 nM). MW=146.3 kDa.

• Supplier: Selleck Chemicals
• Product #: A2013
• Sku #: A2013-1mg